Skip to content
  • About
    • About Pataigin
    • Team
  • Science
    • Science overview
    • Lipid fingerprints
    • BACLIB method
    • Antimicrobial susceptibility
  • Publications
  • News
    • News
    • Media
  • Contact
  • Early access

News

Pataigin Appoints Michael Chen as Medical Director

30 March, 2026

SEATTLE, WA – 30 March, 2026 – Microbiology diagnostics company Pataigin today appointed Michael Chen as Medical Director to facilitate implementation of BACLIB in the clinical diagnostic lab.

Category

  • News

Tag

  • BACLIB-News
← Previous postPataigin Appoints Deborah Elvins as Strategic Advisor
Pataigin

Microbiology at
the speed of life.

  • About
  • Team
  • Science
  • Publications
  • News
  • Media
  • Contact
  • Early access

Seattle, WA · Baltimore, MD · University of Maryland, Baltimore licence

© 2019–2026 Pataigin LLC. This website is for research use only and not for medical use.

  • Terms of Use
  • Privacy Policy
  • Colophon